Re: Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following a complete hydatidiform mole: a historical database review

BJOG. 2016 Sep;123(10):1706. doi: 10.1111/1471-0528.14078.
No abstract available

Publication types

  • Letter
  • Review

MeSH terms

  • Administration, Oral
  • Adult
  • Biomarkers / blood
  • Chorionic Gonadotropin / blood*
  • Contraceptive Agents / administration & dosage*
  • Contraceptive Agents / adverse effects
  • Evidence-Based Medicine
  • Female
  • Humans
  • Hydatidiform Mole / blood*
  • Hydatidiform Mole / chemically induced
  • Hydatidiform Mole / therapy
  • Monitoring, Physiologic
  • Pregnancy
  • Uterine Neoplasms / blood*
  • Uterine Neoplasms / chemically induced
  • Uterine Neoplasms / therapy

Substances

  • Biomarkers
  • Chorionic Gonadotropin
  • Contraceptive Agents